Understand the source comparison
Is Glutathione Legal 2026 Status: Regulatory Comparison
The following table clarifies how glutathione's legal status varies across formulation types, distribution channels, and intended use categories in 2026. Understanding these distinctions prevents compliance violations and ensures appropriate sourcing for speci
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The following table clarifies how glutathione's legal status varies across formulation types, distribution channels, and intended use categories in 2026. Understanding these distinctions prevents compliance violations and ensures appropriate sourcing for specific applications.
- Research-grade powder
- Legal without restriction
- Purity certificate, CAS verification, end-use certification for institutional orders
- Direct sale to laboratories, research institutions, qualified investigators
- Voluntary. No FDA premarket approval required
- Labeled "not for human consumption"; in vitro and animal research only
- Best choice for laboratory studies; no prescription needed; most cost-effective for non-clinical applications
- Compounded injectable (503B)
- Legal via FDA-registered outsourcing facilities
- Facility registration, batch testing, adverse event reporting, ingredient sourcing documentation
- Distribution to healthcare practitioners and dispensing pharmacies
- FDA inspection, cGMP compliance, sterility verification
- Patient administration pursuant to prescription; investigational clinical use under IND
- Required for human clinical trials; higher cost but necessary regulatory pathway
- Compounded injectable (503A)
- Legal via state-licensed pharmacies
- State pharmacy license, patient-specific prescription, practitioner order
- Dispensing only to specific patients with prescriptions
- State pharmacy board regulation; limited FDA oversight
- Individual patient use only; cannot be produced in bulk
- Appropriate for individual patient therapy but not research studies
- Oral supplement (DSHEA-compliant)
- Legal as dietary supplement
- GMP compliance, structure-function claims only (no disease treatment claims), ingredient listing
- Retail sale to consumers without prescription
- FDA post-market surveillance; GMP enforcement
- General wellness; no therapeutic claims permitted
- Legal but bioavailability is significantly lower than injectable; limited research application
- Injectable marketed with therapeutic claims
- Prohibited without FDA approval
- New Drug Application with clinical trial data
- Not legally distributed
- Enforcement action. Warning letters, injunctions, product seizure
- None. Unapproved drug per 21 USC 355
- Illegal regardless of glutathione source or purity; marketing claims trigger drug classification